Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jan;37(1):309-10.
doi: 10.1038/npp.2011.187.

Update on ω-3 polyunsaturated fatty acids in early-stage psychotic disorders

G Paul Amminger  1 , Patrick D McGorry
Affiliations

Update on ω-3 polyunsaturated fatty acids in early-stage psychotic disorders

G Paul Amminger et al. Neuropsychopharmacology. 2012 Jan.
No abstract available

PubMed Disclaimer

References

    1. Amminger GP, Schäfer M, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry. 2010;67:146–154. - PubMed
    1. Assies J, Lieverse R, Vreken P, Wanders RJA, Dingemans PMJA, Linszen DH. Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group. Biol Psychiatry. 2001;49:510–522. - PubMed
    1. Berger GE, Smesny S, Amminger GP. Bioactive lipids in schizophrenia. Int Rev Psychiatry. 2006;18:85–98. - PubMed
    1. Ellison-Wright I, Bullmore E. Meta-analysis of diffusion tensor imaging studies in schizophrenia. Schizophr Res. 2009;108:3–10. - PubMed
    1. McNamara R. Omega-3 fatty acid deficiency: a preventable risk factor for schizophrenia. Schizophr Res. 2011;129:215–216. - PubMed

Publication types

Substances